US Patent Issued to Washington University on Aug. 18 for "Methods of treating cancer and inhibiting TYK2 and MEK" (Missouri Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,622, issued on Aug. 18, was assigned to Washington University (St. Louis).

"Methods of treating cancer and inhibiting TYK2 and MEK" was invented by Angela Hirbe (St. Louis), Dana Borcherding (St. Louis) and Neha Amin (St. Louis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Among the various aspects of the present disclosure is the provision of methods of treating cancer in a subject comprising administering a TYK2 inhibiting agent and a MEK inhibiting agent. In some embodiments, the subject has a malignant peripheral nerve sheath tumor (MPNST), neurofibromatosis Type 1 (NF1) cancer predisposition syndrome, benign plexiform neurofibromas (PN), or at...